AIM ImmunoTech
AIM
#10459
Rank
A$5.3 M
Marketcap
A$1.56
Share price
2.80%
Change (1 day)
-92.36%
Change (1 year)

Earnings for AIM ImmunoTech (AIM)

Earnings in 2025 (TTM): -A$24.75 Million

According to AIM ImmunoTech 's latest financial reports the company's current earnings are A$0.11 Million. In 2024 the company made an earning of -A$24.55 Million, an increase over its 2023 earnings that were of -A$41.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AIM ImmunoTech from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$24.75 Million0.8%
2024 -A$24.55 Million-40.2%
2023 -A$41.05 Million48.94%
2022 -A$27.56 Million1.66%
2021 -A$27.11 Million32.66%
2020 -A$20.44 Million51.18%
2019 -A$13.52 Million-2.81%
2018 -A$13.91 Million18.82%
2017 -A$11.71 Million10.09%
2016 -A$10.64 Million-50.74%
2015 -A$21.59 Million-12.72%
2014 -A$24.74 Million7.55%
2013 -A$23 Million-6.51%
2012 -A$24.6 Million21.22%
2011 -A$20.3 Million-7.56%
2010 -A$21.95 Million16.76%
2009 -A$18.8 Million3.54%
2008 -A$18.16 Million-33.58%
2007 -A$27.34 Million3.18%
2006 -A$26.5 Million89.3%
2005 -A$14 Million-9.31%
2004 -A$15.44 Million50.17%
2003 -A$10.28 Million9.55%
2002 -A$9.39 Million-24.79%
2001 -A$12.48 Million-2.66%
2000 -A$12.82 Million-6.78%
1999 -A$13.75 Million40.58%
1998 -A$9.78 Million6.15%
1997 -A$9.22 Million41.3%
1996 -A$6.52 Million360%
1995 -A$1.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.23 Billion 912.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.74 Million 15.28%๐Ÿ‡บ๐Ÿ‡ธ USA